Vittamed said today it raised $10 million in a Series A round of funding to support its intracranial pressure neurodiagnostic sensor development and launch. The funding round was led by Xeraya Capital Labuan and joined by existing investor Imprimatur Capital and other investors, the Boston-based company said. “The financial support and expertise of Xeraya Capital […]
Medtech maker Vittamed won CE Mark approval for a pair of ultrasound-based systems for monitoring intracranial pressure and cerebral perfusion, the company announced.
European regulators approved Vittamed’s 205 intracranial pressure measurement and the 505 cerebrovascular autoregulation monitor, both of which use non-invasive headsets to monitor activity in the brain.